Your browser is no longer supported. Please, upgrade your browser.
Settings
AMAG AMAG Pharmaceuticals, Inc. daily Stock Chart
AMAG [NASD]
AMAG Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-4.92 Insider Own0.30% Shs Outstand34.49M Perf Week10.01%
Market Cap576.36M Forward P/E- EPS next Y-0.57 Insider Trans0.00% Shs Float34.22M Perf Month0.97%
Income-169.30M PEG- EPS next Q-0.26 Inst Own- Short Float25.37% Perf Quarter-3.13%
Sales474.00M P/S1.22 EPS this Y59.10% Inst Trans0.09% Short Ratio14.87 Perf Half Y-32.62%
Book/sh22.10 P/B0.76 EPS next Y71.60% ROA-13.20% Target Price18.58 Perf Year20.22%
Cash/sh12.40 P/C1.35 EPS next 5Y- ROE-29.50% 52W Range14.35 - 26.10 Perf YTD10.01%
Dividend- P/FCF8.60 EPS past 5Y-52.10% ROI-10.30% 52W High-35.98% Beta0.48
Dividend %- Quick Ratio2.70 Sales past 5Y42.20% Gross Margin54.50% 52W Low16.45% ATR0.72
Employees762 Current Ratio2.90 Sales Q/Q-1.70% Oper. Margin-58.50% RSI (14)56.90 Volatility3.73% 4.60%
OptionableYes Debt/Eq0.37 EPS Q/Q57.50% Profit Margin-47.00% Rel Volume0.74 Prev Close16.32
ShortableYes LT Debt/Eq0.34 EarningsFeb 07 BMO Payout- Avg Volume583.56K Price16.71
Recom3.00 SMA203.95% SMA503.09% SMA200-18.81% Volume436,577 Change2.39%
Dec-14-18Reiterated B. Riley FBR Buy $29 → $20.50
Nov-06-18Downgrade JP Morgan Neutral → Underweight
Jun-15-18Downgrade Janney Buy → Neutral
May-21-18Resumed Leerink Partners Mkt Perform
Mar-14-18Reiterated B. Riley FBR, Inc. Neutral $16 → $23
Feb-15-18Upgrade Janney Neutral → Buy
Dec-07-17Initiated B. Riley FBR, Inc. Neutral $16
Oct-23-17Initiated Piper Jaffray Neutral $18
Sep-08-17Initiated Morgan Stanley Overweight $26
Jan-11-17Downgrade Needham Buy → Hold
Jan-10-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-09-17Downgrade Raymond James Mkt Perform → Underperform
Oct-27-16Initiated Needham Buy $40
May-09-16Reiterated Deutsche Bank Hold $42 → $35
May-04-16Downgrade Raymond James Outperform → Mkt Perform
Jan-21-16Initiated Barclays Equal Weight $32
Nov-19-15Reiterated Deutsche Bank Hold $50 → $43
Sep-03-15Resumed Deutsche Bank Hold $75 → $71
Sep-01-15Initiated Raymond James Outperform $75
Aug-18-15Resumed Jefferies Buy $80
Feb-09-19 03:10PM  Edited Transcript of AMAG earnings conference call or presentation 7-Feb-19 1:00pm GMT Thomson Reuters StreetEvents
Feb-08-19 08:59PM  AMAG Pharmaceuticals (AMAG) Q4 2018 Earnings Conference Call Transcript Motley Fool
10:00AM  AMAG Q4 Loss Narrower Than Expected, Revenues Lag Estimates Zacks
Feb-07-19 08:55AM  AMAG Pharmaceuticals (AMAG) Reports Q4 Loss, Misses Revenue Estimates Zacks -7.60%
07:57AM  AMAG Pharmaceuticals: 4Q Earnings Snapshot Associated Press
07:00AM  AMAG Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update GlobeNewswire
Jan-30-19 08:00AM  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 7, 2019 at 8:00 a.m. ET GlobeNewswire
Jan-17-19 08:00AM  AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals GlobeNewswire
07:30AM  Research Report Identifies Edison International, MPLX LP, Moody's, AMAG Pharmaceuticals, Cross Country Healthcare, and New Mountain Finance with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-15-19 08:00AM  AMAG Pharmaceuticals Appoints Christine Moulton Clemson, Ph.D., M.S.C.I. as Vice President of Medical Affairs GlobeNewswire
Jan-07-19 07:00AM  AMAG Pharmaceuticals Announces Preliminary 2018 Financial Results and Provides 2019 Financial Guidance GlobeNewswire
Dec-27-18 08:25AM  AMAG Up Nearly 10% in a Year on Label Expansion, Acquisitions Zacks
Dec-19-18 08:00AM  AMAG Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-14-18 10:25AM  AMAG to Acquire Ciraparantag Maker Perosphere Pharmaceuticals Zacks
Dec-13-18 06:30AM  AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals GlobeNewswire
Dec-04-18 12:06PM  Estimating The Fair Value Of AMAG Pharmaceuticals Inc (NASDAQ:AMAG) Simply Wall St. -5.11%
Dec-03-18 08:00AM  Study of Feraheme demonstrates Improvements in Fatigue and Quality Of Life in Iron Deficiency Anemia Patients GlobeNewswire
Nov-29-18 12:50PM  Paul Tudor Jones Continues to Buy Apple, Alibaba GuruFocus.com
08:00AM  AMAG Pharmaceuticals Awards Four Grants to Further Research in Preterm Birth and Preeclampsia GlobeNewswire
Nov-26-18 05:37PM  AMAG's Label Expansion of Lead Products Raises Share Price Zacks
Nov-08-18 08:10AM  Detailed Research: Economic Perspectives on KB Home, Lennox International, CorVel, Acorda Therapeutics, PROS, and AMAG Pharmaceuticals What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-07-18 05:31PM  Edited Transcript of AMAG earnings conference call or presentation 1-Nov-18 12:00pm GMT Thomson Reuters StreetEvents +6.20%
Nov-06-18 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Nov-02-18 06:11PM  AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues Zacks
Nov-01-18 05:08PM  Here's Why AMAG Pharmaceuticals Tumbled 12.7% Today Motley Fool -12.74%
12:12PM  AMAG Pharmaceuticals Inc (AMAG) Q3 2018 Earnings Conference Call Transcript Motley Fool
12:10PM  AMAG Pharmaceuticals (AMAG) Reports Q3 Loss, Tops Revenue Estimates Zacks
10:42AM  AMAG Pharmaceuticals: 3Q Earnings Snapshot Associated Press
07:00AM  AMAG Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Oct-29-18 09:02AM  The Zacks Analyst Blog Highlights: Allergan, Regeneron Pharmaceuticals, Amgen, Alnylam Pharmaceuticals and AMAG Pharmaceuticals Zacks
Oct-26-18 04:02PM  5 Drug/Biotech Stocks Likely to Beat Estimates in Q3 Earnings Zacks
Oct-25-18 10:33AM  AMAG Pharmaceuticals (AMAG) Q3 Earnings Preview: What to Watch Ahead of the Release Zacks
08:00AM  AMAG Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Thursday, November 1, 2018 at 8:00 a.m. ET GlobeNewswire
Oct-17-18 08:15AM  Report: Exploring Fundamental Drivers Behind CURO Group, BiondVax Pharmaceuticals, AMAG Pharmaceuticals, AcelRx Pharmaceuticals, Ballard Power, and Rhythm Pharmaceuticals New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-09-18 08:51AM  Is the Options Market Predicting a Spike in AMAG Pharmaceuticals (AMAG) Stock? Zacks
Oct-05-18 08:07AM  New Strong Sell Stocks for October 5th Zacks
Oct-04-18 08:00AM  AMAG Pharmaceuticals and Endoceutics Announce Presentation at the 2018 Annual Meeting of The North American Menopause Society on the Effect of Time Since Menopause, Age and Previous Hormone Therapy on the Response to Intravaginal Prasterone GlobeNewswire
Sep-27-18 11:37AM  AMAG In-Licenses Global Rights to Orphan Drug Candidate Zacks -5.62%
Sep-26-18 06:30AM  AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia GlobeNewswire
Sep-20-18 09:15AM  AMAG Pharmaceuticals Partners With Emmy-Nominated Actress Cheryl Hines and Dr. Marla Shapiro to Start a Conversation About an Often Unrecognized and Untreated Medical Condition, Painful Sex Due to Menopause GlobeNewswire
Sep-13-18 07:30AM  Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results PR Newswire
Sep-06-18 08:00AM  AMAG Pharmaceuticals Pays Off $475 Million of Senior Secured Notes GlobeNewswire
Sep-04-18 10:19AM  Options Traders Expect Huge Moves in AMAG Pharmaceuticals (AMAG) Stock Zacks
Aug-23-18 03:16PM  Edited Transcript of AMAG earnings conference call or presentation 2-Aug-18 12:00pm GMT Thomson Reuters StreetEvents
08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
07:40AM  Factors of Influence in 2018, Key Indicators and Opportunity within AMAG Pharmaceuticals, Pier 1 Imports, Gogo, IDT, Axalta Coating, and Sprouts Farmers Market New Research Emphasizes Economic Growth GlobeNewswire
Aug-10-18 06:19AM  Note to Musk: Tesla isn't the only company targeted by short sellers. Here's who tops the list in Mass. American City Business Journals
Aug-06-18 04:45PM  California Cryobank And Cord Blood Registry Combine To Create A Leading Life Sciences Platform PR Newswire
04:30PM  AMAG Pharmaceuticals Completes Divestiture of Cord Blood Registry® GlobeNewswire
07:30AM  AMAG Pharmaceuticals Appoints Brian Robinson, M.D. as Senior Vice President of Medical Affairs GlobeNewswire
Aug-02-18 12:10PM  AMAG Pharmaceuticals (AMAG) Reports Q2 Loss, Misses Revenue Estimates Zacks
11:04AM  AMAG Pharmaceuticals: 2Q Earnings Snapshot Associated Press
07:00AM  AMAG Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
06:00AM  AMAG Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Jul-26-18 08:00AM  AMAG Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Thursday, August 2, 2018 at 8:00 a.m. ET GlobeNewswire
Jul-17-18 07:05PM  GI Chill Acquisition LLC -- Moody's assigns a B3 CFR to GI Chill Acquisition LLC; stable outlook Moody's
Jun-18-18 08:30AM  Analysis: Positioning to Benefit within The Stars Group, AMAG Pharmaceuticals, ResMed, WestRock, Briggs & Stratton, and II-VI Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jun-15-18 08:33AM  [$$] GI Partners Buys Cord Blood Registry and Sperm and Egg Bank The Wall Street Journal
07:10AM  California Cryobank And Cord Blood Registry To Be Combined By GI Partners To Create A Leading Life Sciences Platform PR Newswire
07:00AM  AMAG Pharmaceuticals Announces Divestiture of Cord Blood Registry® GlobeNewswire
Jun-13-18 07:25AM  Initiating Free Research Reports on ArQule and Three Other Biotech Equities ACCESSWIRE
Jun-11-18 04:44PM  AMAG Pharmaceuticals, Inc. and March of Dimes Announce Collaboration to Improve Health of Mothers and Babies GlobeNewswire
Jun-04-18 07:00AM  AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing for Bremelanotide GlobeNewswire
May-29-18 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conference GlobeNewswire
May-09-18 07:00AM  AMAG Pharmaceuticals Commends CMS for Clarifying Part D Coverage of Treatments for Moderate to Severe Dyspareunia Due to Menopause GlobeNewswire +5.73%
May-08-18 07:30AM  Wired News Auris Medical Reported Publication Related to AM-111 in Peer-Reviewed Scientific Journal Hearing Research ACCESSWIRE +5.31%
May-07-18 05:12AM  Edited Transcript of AMAG earnings conference call or presentation 3-May-18 12:00pm GMT Thomson Reuters StreetEvents
May-04-18 02:17PM  AMAG Pharma (AMAG) Q1 Loss Wider Than Expected, Lifts View Zacks
May-03-18 10:39AM  AMAG Pharmaceuticals: 1Q Earnings Snapshot Associated Press -7.25%
07:00AM  AMAG Pharmaceuticals Announces First Quarter 2018 Financial Results and Raises Full Year Financial Guidance GlobeNewswire
May-02-18 08:00AM  AMAG Pharmaceuticals Appoints J. Alan Butcher as Executive Vice President and Chief Business Officer GlobeNewswire
Apr-30-18 12:34PM  Calculating The Fair Value Of AMAG Pharmaceuticals Inc (NASDAQ:AMAG) Simply Wall St.
Apr-27-18 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Apr-26-18 08:00AM  AMAG Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 3, 2018 at 8:00 a.m. ET GlobeNewswire
Apr-24-18 03:53AM  Investor Expectations to Drive Momentum within AMN Healthcare Services, Cass Information, William Lyon Homes, AMAG Pharmaceuticals, Intersect ENT, and First Financial Discovering Underlying Factors of Influence GlobeNewswire
Apr-10-18 03:17PM  Edited Transcript of AMAG presentation 8-Mar-17 3:25pm GMT Thomson Reuters StreetEvents
Mar-29-18 09:20AM  AMAG Pharma (AMAG) Down 10.6% Since Earnings Report: Can It Rebound? Zacks +8.63%
Mar-26-18 08:00AM  Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women PR Newswire
08:00AM  AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration for Bremelanotide for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women GlobeNewswire
Mar-05-18 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Feb-28-18 09:09AM  AMAG Pharma (AMAG) Beats on Q4 Earnings, Misses on Revenues Zacks
Feb-27-18 08:21PM  Edited Transcript of AMAG earnings conference call or presentation 27-Feb-18 1:00pm GMT Thomson Reuters StreetEvents
11:05AM  AMAG Pharmaceuticals tops Street 4Q forecasts Associated Press
07:00AM  AMAG Reports 2017 Financial Results and Company Update GlobeNewswire
06:15AM  AMAG Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-23-18 09:12AM  These 2 Biotech Stocks Are Soaring. Can They Keep It Up? Motley Fool
Feb-20-18 08:00AM  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast on Tuesday, February 27, 2018 at 8:00 a.m. ET GlobeNewswire
07:30AM  Blog Exposure - FDA Granted Approval to AMAGs Makena(R) Subcutaneous Auto-Injector to Reduce the Risk of Preterm Birth in Certain At-risk Women ACCESSWIRE
Feb-16-18 03:55PM  AMAG Pharmaceuticals, Inc. -- Moody's says AMAG's Makena auto injector approval is credit positive; ratings unaffected at this time Moody's
08:00AM  Recent Analysis Shows SBA Communications, AMAG Pharmaceuticals, Galectin Therapeutics, Xilinx, J.B. Hunt Transport Services, and Southern Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Feb-15-18 04:31PM  This Biotech Stock Pops 30% On FDA Nod 'Slamming Door' On Woes Investor's Business Daily +29.14%
01:45PM  Why AMAG Pharmaceuticals, Inc. (AMAG) Shares Are Skyrocketing Today InvestorPlace
12:05PM  Why AMAG Pharmaceuticals, Inc. and Antares Pharma, Inc. Are Soaring Today Motley Fool
08:02AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:13AM  Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector MarketWatch
Feb-14-18 06:21PM  Antares Pharma Announces FDA Approval of Partners Product Utilizing Our QuickShot Auto Injector GlobeNewswire
06:03PM  AMAG Pharmaceuticals Announces FDA Approval of Makena® (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector to Reduce the Risk of Preterm Birth in Certain At-Risk Women GlobeNewswire
Feb-12-18 02:06PM  The Week Ahead: Earnings, FDA Actions, And Industry Conferences To Watch Benzinga
Feb-05-18 08:00AM  AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for Feraheme® (ferumoxytol injection) GlobeNewswire -7.34%
Jan-31-18 06:12AM  Vertex (VRTX) & Other Drug Stocks with FDA Catalysts this February Zacks
AMAG Pharmaceuticals, Inc., a biopharmaceutical company, manufactures, develops, and commercializes therapeutics for maternal and women's health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, as well as patients who have chronic kidney disease; Intrarosa(prasterone) vaginal insert steroid for the treatment of dyspareunia due to menopause; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company also offers Cord Blood Registry services that are related to the collection, processing, and storage of umbilical cord blood and cord tissue units for pregnant women and their families. In addition, it has an option agreement with Velo Bio LLC to acquire the rights to digoxin immune fab, a polyclonal antibody, which is in Phase IIb/IIIa trial for the treatment of severe preeclampsia in pregnant women. The company sells Feraheme to authorized wholesalers and specialty distributors. It has a license agreement with Palatin Technologies, Inc. to research, develop, and commercialize Bremelanotide, an investigational product for the treatment of hypoactive sexual desire disorder (HSDD) in pre-menopausal women, as well as with Endoceutics, Inc. to develop and commercialize pharmaceutical products with dehydroepiandrosterone; and development and license agreement with Antares Pharma, Inc. to develop, use, sell, offer for sale, and import and export the Makena auto-injector. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEIDEN WILLIAM KPresident & CEOAug 07Sale25.005,000125,000328,015Aug 08 05:17 PM
HEIDEN WILLIAM KPresident & CEOJun 04Sale25.0020,000500,000333,015Jun 05 07:21 AM
Vittiglio JosephEVP, General CounselMar 06Sale20.8077016,01652,854Mar 06 07:25 PM